Holen Sie sich die Stockscreener-App
38.82
2.21%
0.84
Schlusskurs vom Vortag:
$37.98
Offen:
$38.04
24-Stunden-Volumen:
186.99K
Relative Volume:
0.79
Marktkapitalisierung:
$1.58B
Einnahmen:
$1.50B
Nettoeinkommen (Verlust:
$95.23M
KGV:
16.68
EPS:
2.328
Netto-Cashflow:
$12.77M
1W Leistung:
+1.36%
1M Leistung:
+9.97%
6M Leistung:
-27.95%
1J Leistung:
+0.65%
1-Tages-Spanne:
$37.24
$38.94
1-Wochen-Bereich:
$36.53
$39.64
52-Wochen-Spanne:
$28.25
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, TEVA, HLN, ZTS, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
38.82 | 1.58B | 1.50B | 95.23M | 12.77M | 2.328 |
TAK
Takeda Pharmaceutical Co Adr
|
19.67 | 62.84B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.50 | 48.40B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
10.13 | 44.55B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
79.38 | 32.80B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
533.12 | 22.87B | 3.17B | 1.29B | 1.01B | 27.09 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-15 | Eingeleitet | Citigroup | Neutral |
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Reasons to Add STE Stock to Your Portfolio Right Now - Zacks Investment Research
Haemonetics Gains 149.3% in a Year: What's Driving the Rally? - Zacks Investment Research
Is it Apt to Retain Medtronic Stock in Your Portfolio Now? - Zacks Investment Research
Is it Apt to Retain Prestige Consumer Stock in Your Portfolio Now? - Zacks Investment Research
Is it the Right Time to Hold TNDM Stock in Your Portfolio? - Zacks Investment Research
Is it the Right Time to Add Phibro Stock to Your Portfolio? - Zacks Investment Research
Encompass Health Expands Rehab Footprint With New Maine Hospital - Zacks Investment Research
Is This the Right Time to Add TMO Stock to Your Portfolio? - Zacks Investment Research
Neogen Stock Rallies 83% YTD: What's Driving the Surge? - Zacks Investment Research
Should You Continue to Hold IART Stock in Your Portfolio? - Zacks Investment Research
Chewy's Vet Care Posts Triple-Digit Growth as Clinic Scale Builds - Zacks Investment Research
Is This the Right Time to Add Labcorp Stock to Your Portfolio? - Zacks Investment Research
Phibro Animal Health (NasdaqGM:PAHC) Stock Forecast & Analyst Predictions - Simply Wall Street
Phibro Animal Health CFO David Glenn Granted 3,482 Shares, Increasing Holdings to 54,959 - Kalkine Media
Phibro Animal Health (PAHC) updates CFO’s 3,482-unit stock grant - Stock Titan
COO stock award takes Phibro Animal Health (PAHC) stake to 38,275 units - Stock Titan
Big Phibro Animal Health (PAHC) investor lines up stock sale plan - Stock Titan
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference - Yahoo Finance
Phibro Animal Health Corporation to Participate in Morgan Stanley Annual Global Healthcare Conference - Business Wire
Phibro Animal Health (PAHC) Sets 2027 Guidance, Is The Stock Still A Bargain? - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Surge 3.9% -- What GF Sc - GuruFocus
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? - Yahoo Finance
Understanding Phibro (PAHC) Reliance on International Revenue - Yahoo Finance
Teleconferência de Resultados do 4º Trimestre Fiscal e do Ano Fiscal de 2026 da PAHC: Crescimento das Vendas, Guidance para 2027 e Risco Brasil - TradingKey
Phibro Animal Health Corporation Class A (PAHC) Peer Comparison – Compare with Others - Value Research
Phibro Animal Health Corporation Class A (PAHC) Key Financial Ratios – Valuation, Profitability & More - Value Research
Phibro Animal Health Corporation Class A (PAHC) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
PAHC Q2 Deep Dive: Diverse Portfolio Offsets Regulatory and Margin Headwinds - Yahoo Finance
Phibro Animal Health declares $0.12 quarterly dividend - scanx.trade
Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates - Investing.com
Earnings call transcript: Phibro Animal Health tops Q4 2026 estimates By Investing.com - Investing.com India
Phibro Q4 FY26 slides: record year, margins expand on Zoetis deal - investing.com
PAHC SWOT Analysis: Strong Growth Potential Amidst Valuation Con - GuruFocus
Is Phibro Animal Health Corp (PAHC) Overvalued After Q4 Earnings - GuruFocus
Phibro Animal Health Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Phibro Animal Health Submits Annual 10-K Report for Fiscal Year Ending June 30, 2026 - Kalkine Media
(PAHC) Phibro Animal Health Expects Fiscal 2027 Revenue Range $1.55B$1.60B, vs. FactSet Est of $1.55B - marketscreener.com
Earnings Flash (PAHC) Phibro Animal Health Posts Fiscal Q4 Revenue $396.7M, vs. FactSet Est of $381.2M - marketscreener.com
Phibro Animal Health Corporation (PAHC) Stock Rises on Q4 2026 Earnings - Quiver Quantitative
Phibro Animal Health jumps 5% on strong Q4 earnings and guidance beat - Investing.com
PHIBRO ANIMAL HEALTH CORP FY 2026: Revenue $1.52B, EPS $2.43— 10-K Summary - TradingView
Phibro: Fiscal Q4 Earnings Snapshot - KVUE
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance - Yahoo Finance
Phibro Animal Health sets FY27 adj EPS $3.41-$3.59, beats est - scanx.trade
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance - Business Wire
JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com Nigeria
JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com Canada
JPMorgan reiterates Phibro Animal Health stock rating on solid outlook By Investing.com - Investing.com India
Earnings To Watch: Phibro Animal Health (PAHC) Reports Q2 Results Tomorrow - Yahoo Finance
Phibro Animal Health Corp (PAHC) Shares Surge 3.2% -- What GF Sc - GuruFocus
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Phibro Animal Health Corp-Aktie (PAHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weinstein Judith | Officer |
Aug 04 '26 |
Proposed Sale |
36.60 |
472 |
17,275 |
0 |
| Bendheim Daniel M | Officer |
Aug 04 '26 |
Proposed Sale |
36.60 |
486 |
17,787 |
0 |
| Escudero Lisa Ann | Officer |
Aug 04 '26 |
Proposed Sale |
36.60 |
265 |
9,699 |
0 |
| David Glenn | Officer |
Aug 04 '26 |
Proposed Sale |
36.60 |
840 |
30,744 |
0 |
| BENDHEIM JACK | Officer |
Aug 04 '26 |
Proposed Sale |
36.60 |
2,303 |
84,288 |
0 |
| Miller Larry Lee | Officer |
Aug 04 '26 |
Proposed Sale |
36.60 |
635 |
23,241 |
0 |
| BFI Co. LLC | 10% Owner |
Jun 16 '26 |
Proposed Sale |
31.87 |
281,600 |
8,974,592 |
0 |
| CORCORAN E THOMAS | Director |
May 29 '26 |
Buy |
31.77 |
10,000 |
317,700 |
41,459 |
| BENDHEIM JACK | President and CEO |
May 07 '26 |
Sale |
48.49 |
4,528 |
219,568 |
56,152 |
| BENDHEIM JACK | President and CEO |
May 06 '26 |
Sale |
57.37 |
7,040 |
403,850 |
60,680 |
0.01%
1.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):